The Viral Pseudotype Unit was established in 2010 to act as an interface between academia, industry and public/animal health laboratories with the purpose of translating basic virus research (on viral pseudotypes) into in vitro cell culture-based assays that can be readily employed for the immunogenicity testing of preclinical vaccine candidates, and for the functional screening of new antivirals and therapeutic antibodies. More recently the Viral Pseudotype Unit has become involved with the exploitation of pseudotypes for the development of serological standards, and with training and education via traditional and new media platforms.